Prostate-specific Antigen Density as a Proxy for Predicting Prostate Cancer Severity: Is There Any Difference between Systematic and Targeted Biopsy?

BACKGROUND: Prostate cancer screening with prostate-specific antigen (PSA) can result in unnecessary biopsies and overdiagnosis. Alternately, PSA density (PSAD) calculation may help support biopsy decisions; however, evidence of its usefulness is not concrete. OBJECTIVE: To evaluate the predictive v...

Descripción completa

Detalles Bibliográficos
Autores principales: Arafa, Mostafa A., Farhat, Karim Hamda, Rabah, Danny M., Khan, Farrukh K., Mokhtar, Alaa, Al-Taweel, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634460/
https://www.ncbi.nlm.nih.gov/pubmed/37970462
http://dx.doi.org/10.4103/sjmms.sjmms_49_23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634460/
https://www.ncbi.nlm.nih.gov/pubmed/37970462
http://dx.doi.org/10.4103/sjmms.sjmms_49_23

Ejemplares similares